Related Experiment Video
Updated: Nov 15, 2025
07:59
Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
Published on: July 28, 2018
11.5K
Diuretic therapy in congestive heart failure.
Patrick Kennelly1,2, Rajju Sapkota2,3, Maimoona Azhar1,4
1Graduate Entry Medicine, School of Medicine, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
Acta Cardiologica
|March 3, 2021
Summary
Diuretics manage heart failure symptoms but cause complications. Safer alternatives are needed to effectively treat fluid overload and improve patient outcomes in congestive heart failure.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Fluid overload is a key issue in heart failure, causing congestion.
- Diuretics are crucial for managing heart failure symptoms.
- Current diuretic use faces challenges like side effects and resistance.
Purpose of the Study:
- To review diuretic use in congestive heart failure.
- To discuss complications associated with different diuretics.
- To explore safer alternatives for fluid management.
Main Methods:
- Literature review of diuretic therapy in heart failure.
- Analysis of complications: electrolyte imbalance, renal function, resistance.
- Evaluation of alternative strategies for congestion management.
Main Results:
- Diuretics effectively relieve congestive symptoms.
- Common complications include electrolyte abnormalities and worsening renal function.
- Diuretic resistance necessitates alternative approaches.
Conclusions:
- Optimizing diuretic use is essential for heart failure management.
- Understanding and mitigating complications is critical.
- Further research into safer, effective alternatives is warranted.
Related Concept Videos
01:22Heart Failure Drugs: Diuretics
608
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
608
01:22Heart Failure VI: Adjunct Therapies
101
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
101
01:30Heart Failure V: Medical Management
85
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
85
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
666
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
666
01:30Cardiomyopathy II: Dilated Cardiomyopathy
146
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
146
01:29Heart Failure II: Pathophysiology
200
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
200